MULTIPLE
THERAPIES,
ONE VIRUS.
KALIVIR is developing cutting-edge, next-generation oncolytic viral immunotherapy programs for treatment of cancer. PRESENTATIONS READ MORE Dec 13, 2022 – KaliVir Immunotherapeutics Establishes Clinical and Scientific Advisory Boards READ MORE NEWS AND EVENTS Novel Vaccinia Enhanced Template (VET) Oncolytic Platform
LEARN MORE